WebChang JY, Senan S, Paul MA, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. … WebSuresh Senan is the Professor of Clinical Experimental Radiotherapy at the Amsterdam University Medical Centers (VUmc location), The Netherlands. He completed training in …
Stereotactic ablative RT (SABR) for early stage NSCLC
WebSuresh Senan Background and Purpose MR-guided radiotherapy (MRgRT) with real-time intra-fraction tumor motion monitoring allows for high precision SABR. This study aimed to investigate the... WebJan 25, 2016 · Suresh Senan. Honoraria: Varian Medical Systems. Consulting or Advisory Role: Varian Medical Systems. Research Funding: Company: Varian Medical Systems. Other Relationship: Member of the Trial Management Group (noncompensated) for the PROCLAIM study sponsored by Lilly Oncology; it is evaluating concurrent chemoradiotherapy … historia ya eng hersi said
Speakers - The Lancet Summit
WebSuresh Senan, Department of Radiation Oncology Amsterdam University Medical Center. Disclosures. • Departmental research grants: Varian Medical Systems, AstraZeneca, … WebTreatment of large stage I-II lung tumors using stereotactic body radiotherapy (SBRT): planning considerations and early toxicity Authors Chin Loon Ong 1 , David Palma , Wilko … WebFeb 2, 2024 · Suresh Senan Honoraria: AstraZeneca Consulting or Advisory Role: AstraZeneca, Merck Sharp & Dohme Oncology, BeiGene, Pfizer Research Funding: ViewRay (Inst), AstraZeneca (Inst), Varian Medical Systems (Inst), Bristol Myers Squibb (Inst) Jarushka Naidoo Honoraria: Bristol Myers Squibb, AstraZeneca/MedImmune, Merck, … historia ya emmanuel tutuba